Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Avistone Pharmaceuticals Logo
Avistone Pharmaceuticals Growth Score
86
CB Rank
50402
Heat Score
40
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Founded
obfuscation
PrivateSeries B Beijing, Beijing, China251-500 en.avistonebio.com
Biotechnology
Oncology
Overview

Avistone Pharmaceuticals
Total Funding
obfuscation
Growth Score
86
Heat Score
40

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score86
-1 pts
in past quarter
Heat Score 40
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Avistone Pharmaceuticals

CB Rank
50402
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Founded
obfuscation
PrivateSeries B Beijing, Beijing, China251-500 en.avistonebio.com
Biotechnology
Oncology

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Beijing Anshi Biotechnology Co., Ltd.
Also Known As 鞍石生物科技, Anshi Biotechnology, Beijing Anshi Biotechnology
Operating Status Active
Company Type For Profit
Founders  Hepeng Shi
About the Company
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Phone Number 010- 84148921
Contact Email contact@avistonebio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Vebreltinib
A small-molecule selective MET inhibitor used to treat non-small cell lung cancer (NSCLC) and glioma by inhibiting the activation of the MET pathway.
Andatinib (PLB1004)
A small-molecule inhibitor for epidermal growth factor receptor (EGFR) used to treat late-stage non-small cell lung cancer caused by EGFR mutation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B
obfuscation
Series B - Avistone Pharmaceuticals Logo
Series B - Avistone Pharmaceuticals
5
obfuscation
IDG Capital, SDIC Fund ManagementSeries B

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 1

Employee Profiles

News

News and Press

News•Jan 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 14, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 20, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

9Avistone Pharmaceuticals is actively using 9 technologies for its website, according to BuiltWith. These include Common Crawl, DNSSEC, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Avistone Pharmaceuticals's headquarters? Avistone Pharmaceuticals is located in Beijing, Beijing, China.Who invested in Avistone Pharmaceuticals? Avistone Pharmaceuticals has 7 investors including Bain Capital and  SDIC Fund Management.When was the last funding round for Avistone Pharmaceuticals? Avistone Pharmaceuticals closed its last funding round on
obfuscation
from a Series B round.Who are Avistone Pharmaceuticals's competitors? Alternatives and possible competitors to Avistone Pharmaceuticals may include Novartis, AstraZeneca, and  Roche.How much funding has Avistone Pharmaceuticals raised to date? Avistone Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|